CN113624894A - Method for detecting nitrosamine impurities in biapenem - Google Patents

Method for detecting nitrosamine impurities in biapenem Download PDF

Info

Publication number
CN113624894A
CN113624894A CN202111189528.4A CN202111189528A CN113624894A CN 113624894 A CN113624894 A CN 113624894A CN 202111189528 A CN202111189528 A CN 202111189528A CN 113624894 A CN113624894 A CN 113624894A
Authority
CN
China
Prior art keywords
solution
methanol
detection method
mixed solvent
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111189528.4A
Other languages
Chinese (zh)
Other versions
CN113624894B (en
Inventor
陈新国
邱全玉
邵广志
黄军建
陈亿展
曹丹
麦华凤
蒋杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Gb Inspection And Testing Co ltd
Original Assignee
Guangzhou Gb Inspection And Testing Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Gb Inspection And Testing Co ltd filed Critical Guangzhou Gb Inspection And Testing Co ltd
Priority to CN202111189528.4A priority Critical patent/CN113624894B/en
Publication of CN113624894A publication Critical patent/CN113624894A/en
Application granted granted Critical
Publication of CN113624894B publication Critical patent/CN113624894B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/30Control of physical parameters of the fluid carrier of temperature
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/32Control of physical parameters of the fluid carrier of pressure or speed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/32Control of physical parameters of the fluid carrier of pressure or speed
    • G01N2030/324Control of physical parameters of the fluid carrier of pressure or speed speed, flow rate

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Library & Information Science (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The application belongs to the technical field of drug analysis. The application provides a detection method of nitrosamine impurities in biapenem, which comprises the following steps: adding a sample to be tested into a methanol solution of an internal standard substance for dissolving, and then adding a mixed solvent for uniformly mixing to obtain a sample solution; respectively injecting the sample solution and the reference solution into a liquid chromatography-tandem mass spectrometer, and detecting the content of nitrosamine impurities according to an internal standard method; wherein the mixed solvent comprises methanol, formic acid and water. The method is developed according to the characteristics of the nitrosamine compound, so that the influence of the matrix effect can be effectively reduced, and the object to be detected is prevented from being inhibited. The detection method is verified from the aspects of specificity, linearity, range, detection limit, quantification limit, accuracy, stability and the like, and the method is confirmed to be suitable for simultaneously determining the contents of NDEA, EIPNA and DIPINA in biapenem.

Description

Method for detecting nitrosamine impurities in biapenem
Technical Field
The application belongs to the technical field of pharmaceutical analysis, and particularly relates to a detection method of nitrosamine impurities in biapenem.
Background
Biapenem is a carbapenem synthetic antibiotic, and nitrosamine byproducts such as N-nitrosodiethylamine, N-nitrosoethyl isopropylamine and N-nitrosodiisopropylamine are generated in the production process. Nitrosamines are potent carcinogens, and not only can cause carcinogenesis in animals or humans in long-term small doses, but also can cause carcinogenesis in a single "shock" of higher doses.
At present, the detection method of nitrosamine impurities mainly comprises a gas chromatography thermal energy analysis method, a spectrophotometry method, a gas method and a liquid method, but the existing detection method lacks a detection method aiming at N-nitrosoethyl isopropylamine and N-nitrosodiisopropylamine. Meanwhile, the limit (0.022 ppm) of nitrosamine impurities in biapenem is extremely low, the requirement on detection sensitivity is high, and the requirement on quantitative monitoring of nitrosamine impurities in biapenem is difficult to realize by the existing detection method.
Disclosure of Invention
In view of the above, the present application provides a method for detecting nitrosamine impurities in biapenem, which can realize synchronous measurement of N-nitrosodiethylamine, N-nitrosoethylisopropylamine and N-nitrosodiisopropylamine, and has excellent sensitivity.
The specific technical scheme of the application is as follows:
a method for detecting nitrosamine impurities in biapenem is characterized by comprising the following steps:
s1: adding a sample to be tested into a methanol solution of an internal standard substance for dissolving, and then adding a mixed solvent for uniformly mixing to obtain a sample solution;
s2: respectively injecting the sample solution and the reference solution into a liquid chromatography-tandem mass spectrometer, and detecting the content of nitrosamine impurities according to an internal standard method;
wherein the mixed solvent comprises methanol, formic acid and water.
Preferably, the content of methanol in the methanol solution is 50-80%.
Preferably, the volume ratio of formic acid, methanol and water in the mixed solvent is 5:10: 85.
Preferably, the concentration of the internal standard substance in the methanol solution is 30-60 ng/ml.
Preferably, the volume ratio of the methanol solution to the mixed solvent is 1: 20-30.
Preferably, the concentration of the sample in the sample solution is 40-80 mg/ml, and the concentration of the reference solution is 3-130 ng/ml.
Preferably, the nitrosamine-type impurities include N-nitrosodiethylamine, N-nitrosoethylisopropylamine and/or N-nitrosodiisopropylamine.
Preferably, the liquid chromatography conditions are: a chromatographic column: a C18 chromatography column; mobile phase A: 0.1% formic acid, mobile phase B: methanol; the column temperature is 38-42 ℃; the flow rate is 0.27-0.33 ml/min.
Preferably, the elution procedure of the liquid chromatography is: 0-3 min, A95% and B5%; 3.5-4.5 min, A90% and B10%; 5.5-6.5 min, A60% and B40%; 7-8 min, A20% and B80%; 8.1-9.5 min, A0% and B100%; 9.6-12 min, A95% and B5%.
Preferably, the mass spectrometry conditions are: ion source APCI source, scan mode MRM, ion pair comprising: 117.1/75.1, 131.1/89.1 and/or 103.1/47.0, and the collision energy is 15-29V.
To sum up, the application provides a method for detecting nitrosamine impurities in biapenem, which comprises the following steps: adding a sample to be tested into a methanol solution of an internal standard substance for dissolving, and then adding a mixed solvent for uniformly mixing to obtain a sample solution; respectively injecting the sample solution and the reference solution into a liquid chromatography-tandem mass spectrometer, and detecting the content of nitrosamine impurities according to an internal standard method; wherein the mixed solvent comprises methanol, formic acid and water. The method is developed according to the characteristics of the nitrosamine compound, so that the influence of the matrix effect can be effectively reduced, and the object to be detected is prevented from being inhibited. The detection method is verified from the aspects of specificity, linearity, range, detection limit, quantification limit, accuracy, stability and the like, and the method is confirmed to be suitable for simultaneously determining the contents of NDEA, EIPNA and DIPINA in biapenem.
Drawings
In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings needed to be used in the description of the embodiments or the prior art will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present application, and it is obvious for those skilled in the art that other drawings can be obtained according to the drawings without inventive exercise.
FIG. 1 is a chromatogram of EIPNA specific for a control solution of example 2 of this application;
FIG. 2 is a chromatogram of a specific value of DIPINA in a control solution of example 2 of the present application;
FIG. 3 is a chromatogram of NDEA from a control solution of example 2 of the present application;
FIG. 4 is a chromatogram of EIPNA specific in a spiked solution according to example 2 of the present application;
FIG. 5 is a chromatogram of a specificity of DIPINA in a spiked solution according to example 2 of the present application;
FIG. 6 is a chromatogram of NDEA from a spiked solution according to example 2 of the present application;
FIG. 7 is a chromatogram of EIPNA in comparative example 1 of this application;
FIG. 8 is a chromatogram of DIPINA in comparative example 1 of the present application;
FIG. 9 is a chromatogram of NDEA from comparative example 1 of the present application;
FIG. 10 is a chromatogram of EIPNA in comparative example 4 of this application;
FIG. 11 is a chromatogram of DIPINA in comparative example 4 of the present application;
FIG. 12 is a chromatogram of NDEA from comparative example 4 of the present application;
FIG. 13 is a chromatogram of EIPNA in comparative example 6 of this application;
FIG. 14 is a chromatogram of DIPINA from comparative example 6 of the present application;
FIG. 15 is a chromatogram of NDEA from comparative example 6 of the present application;
FIG. 16 is a chromatogram of EIPNA in comparative example 8 of this application;
FIG. 17 is a chromatogram of DIPINA in comparative example 8 of the present application;
FIG. 18 is a chromatogram of NDEA from comparative example 8 of the present application.
Detailed Description
In order to make the objects, features and advantages of the present application more obvious and understandable, the technical solutions in the embodiments of the present application are clearly and completely described, and it is obvious that the embodiments described below are only a part of the embodiments of the present application, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
The reagents and raw materials used in the examples of the present application are commercially available or self-made.
Example 1
1. Liquid chromatography conditions: a chromatographic column: waters ACQUITY UPLC HSS T3 column (1.8 μm, 2.1 mm. times.100 mm); mobile phase A: 0.1% formic acid-water, mobile phase B: methanol; the column temperature is 40 ℃; the flow rate is 0.3 ml/min;
the elution procedure was: 0-3 min, A95% and B5%; 3.5-4.5 min, A90% and B10%; 5.5-6.5 min, A60% and B40%; 7-8 min, A20% and B80%; 8.1-9.5 min, A0% and B100%; 9.6-12 min, A95% and B5%.
2. Mass spectrum conditions: ion source APCI source, scan mode MRM, ion pair: n-nitrosoethyl isopropylamine (EIPNA) 117.1/75.1, collision energy 15V; n-nitrosodiisopropylamine (DIPINA) 131.1/89.1, collision energy 15V; N-Nitrosodiethylamine (NDEA) 103.1/47.0, collision energy 29V; internal standard NDEA-d 4107.0/77.0, collision energy 16V; internal standard NDPA-d 14145.0/50.0, collision energy 19V.
3. Preparing a mixed solvent: 20ml of methanol is put into a reagent bottle, 170ml of water is added, 10ml of formic acid is added, and the mixture is shaken up.
4. Control solution: respectively taking EIPNA, DIPINA and NDEA standard substances, dissolving with 70% methanol as a solvent, performing gradient dilution with a mixed solvent as a diluent, and preparing a standard curve solution with the concentration of 0.066-2.639 ng/ml.
5. Internal standard solution: taking NDEA-d4 and NDPA-d14 internal standard substances, and using 70% methanol as a solvent to prepare a mixed internal standard solution with the concentration of 33 ng/ml.
6. Test solution: taking about 0.3g of biapenem raw material powder, placing the biapenem raw material powder in a 5ml volumetric flask, adding 0.2ml of internal standard solution, adding mixed solvent to a constant volume to a scale, uniformly mixing, and shaking up.
7. Adding a standard solution: taking about 0.3g of biapenem raw material powder, placing the biapenem raw material powder in a 5ml volumetric flask, adding 0.2ml of internal standard solution, then adding 0.1ml of control solution with the concentration of 66ng/ml, using mixed solvent to fix the volume to a scale, uniformly mixing, and shaking up.
And (3) performing analysis and detection by adopting an internal standard method, namely calculating the peak area ratio of the analytes (EIPNA, DIPINA and NDEA) to the internal standard substances (NDPA-d 14 and NDEA-d 4), and recording the chromatogram and the recovery rate.
Example 2
Referring to the test method of example 1, the test results are as follows:
1. specificity
Respectively taking a reference substance solution with the concentration of 1.319 ng/ml and a standard solution for sample loading test, and recording chromatograms as shown in figures 1-6. The figure shows that the peak position of the target peak in the 100% limit concentration standard sample solution has no other impurity interference, and the peak shape is similar to the peak shape of the 100% limit concentration reference sample solution, which indicates that the detection method has good specificity.
2. Linearity
A standard curve solution is taken for sample loading test, and a linear fitting equation is obtained through the relation between the peak area and the concentration, and is shown in the following table 1. In each concentration range of each impurity, the peak area ratio and the concentration have good linear relation, and the correlation coefficient r is not less than 0.995, thereby meeting the requirements.
TABLE 1
Figure 965096DEST_PATH_IMAGE001
3. Detection limit and quantification limit
And (3) sampling and detecting the reference substance solution with the concentration of 0.066ng/ml for 3 times. The detection limit of NDEA is 0.066ng/ml, which is equivalent to 5% of the limit concentration and can be detected (namely the detection limit is 0.0011 ppm), and the signal-to-noise ratio is 18.1-23.8; the detection limit concentration of EIPNA is 0.066ng/ml, which is equivalent to 5% of the limit concentration and can be detected (namely the detection limit is 0.0011 ppm), and the signal-to-noise ratio is 62.8-65.2; the detection limit concentration of DIPINA is 0.066ng/ml, which is equivalent to 5% of the limit concentration and can be detected (namely the detection limit is 0.0011 ppm), and the signal-to-noise ratio is 23.2-28.8.
0.132ng/ml of control solution is injected and tested for 6 times. The limit concentration of NDEA is 0.132ng/ml, which is equal to 10% of the limit concentration (namely the limit of quantitation is 0.0022 ppm), the signal-to-noise ratio is 32.5-41.4, and the RSD value of the peak area ratio of 6 continuous pins of limit solution is 6.6%; the limit concentration of EIPNA is 0.132ng/ml, which is equivalent to 10% of the limit concentration (namely the limit of quantitation is 0.0022 ppm), the signal-to-noise ratio is 81.3-120.5, and the RSD value of the peak area ratio of 6 continuous pins of limit solutions is 6.0%; the limit concentration of the DIPINA is 0.132ng/ml, which is equivalent to 10% of the limit concentration (namely the limit of the quantification is 0.0022 ppm), the signal-to-noise ratio is 32.4-48.6, and the RSD value of the peak area ratio of 6 continuous pins of the limit solution is 6.5%, thus meeting the requirement.
4. Accuracy of
Taking 3 parts of different standard solutions (corresponding to standard sample solutions with the limit concentrations of each impurity of 50%, 100% and 150%), respectively injecting samples for 1 time, recording chromatograms, and calculating the recovery rate as shown in the following tables 2-4. The recovery rates of NDEA, EIPNA and DIPINA in 9 parts of accuracy solutions are respectively in the ranges of 74.7-97.4%, 72.6-91.2% and 75.0-99.2%, the RSD values are respectively 10.2%, 8.1% and 7.3%, and the accuracy results meet the regulations.
TABLE 2
Figure 985004DEST_PATH_IMAGE002
TABLE 3
Figure 253175DEST_PATH_IMAGE003
TABLE 4
Figure 307718DEST_PATH_IMAGE004
5. Stability of
Respectively taking a reference substance solution and a standard solution with the concentration of 1.319 ng/ml, respectively placing the reference substance solution and the standard solution for at least 24 hours at room temperature (10-30 ℃) in a dark condition, carrying out sample injection analysis at different time points, and recording a chromatogram and the recovery rate, wherein the results are shown in the following table 5-6. The determination concentrations of NDEA, EIPNA and DIPINA in the 100% limit concentration reference substance solution at different times are respectively 94.3% -107.9%, 85.0% -99.0% and 85.8% -109.7% of the initial concentration. The determination concentrations of NDEA, EIPNA and DIPINA in the standard sample solution with 100% limit concentration are respectively 82.5% -96.7%, 79.1% -93.8% and 92.8% -104.1% of the initial concentration. The results show that the impurities NDEA, EIPNA and DIPINA are stable for at least 48h in the reference solution with 100% limit concentration and the standard solution with 100% limit concentration.
TABLE 5
Figure 268721DEST_PATH_IMAGE005
TABLE 6
Figure 41505DEST_PATH_IMAGE006
Comparative example 1
Referring to the detection method of example 1, the difference is that no internal standard solution is added to the spiked solution, and the spiked solution is detected by an external standard method, i.e., peak areas of the recovery rate solution of the analyte (EIPNA, DIPINA, NDEA) and the control solution are calculated, and the average value is taken by repeating 3 times to record the chromatogram and the recovery rate.
Chromatograms of EIPNA, DIPINA and NDEA in the standard solution are shown in FIGS. 7-9, and the recovery rates are 77.2%, 81.5% and 38.9%, respectively. In the recovery rate solution, other components are eluted before the peak emergence of NDEA, the spectrum shows a cracked peak and has a matrix inhibition effect on NDEA, so that the external standard method is not suitable for detecting nitrosamine impurities in biapenem.
Comparative example 2
Referring to the test method of example 1, the only difference was that the mixed solvent in both the control solution and the spiked solution was replaced with 70% methanol, and it was observed that the sample powder was not completely dissolved, the spiked solution had poor solubility, and the recovery rate was unsatisfactory.
Comparative example 3
Referring to the test method of example 1, the difference is only that the mixed solvent in both the control solution and the spiked solution was replaced with 70% methanol, and 0.5ml DMSO was added, and the test was repeated 3 times, and the recovery rate of the spiked solution was recorded.
The recovery rates of EIPNA, DIPINA and NDEA in the standard solution are 90.7-96.5%, 90.7-96.5% and 85.3-101.3% respectively, and are qualified, but the standard solution is precipitated after being placed for 4 hours, so that the sample introduction repeatability and the detection stability are influenced, and the standard solution is not qualified.
Comparative example 4
Referring to the test method of example 1, the difference is that the mixed solvent in both the control solution and the spiked solution was replaced with 10% methanol-2% formic acid solution, the measurement was repeated 3 times to obtain an average value, and the recovery rate of the spiked solution was recorded.
Chromatograms of EIPNA, DIPINA and NDEA in the standard solution are shown in figures 10-12, the standard solution is good in solubility, the recovery rates of EIPNA, DIPINA and NDEA in the standard solution are respectively 98.2%, 81.6% and 86.5%, the recovery rates basically meet requirements, and the recovery rate of DIPINA is low. In addition, the labeling solution is placed under a refrigeration condition, so that precipitation is generated, and the sample introduction repeatability and the detection stability are influenced.
Comparative example 5
Referring to the test method of example 1, the difference was that the mixed solvent in both the control solution and the spiked solution was replaced with 10% methanol-2% formic acid solution, and 0.5ml ammonia water was added for neutralization, and the measurement was repeated 3 times to record the recovery rate of the spiked solution.
The experimental result shows that the peak shape of the control solution is not affected, but the object to be tested is inhibited in the standard solution, wherein the NDEA recovery rate is 0.
Comparative example 6
Referring to the detection method of example 1, the only difference is that the mixed solvent in the control solution and the spiked solution was replaced with 10% methanol-2% formic acid solution, and the elution procedure was adjusted to: 0-1 min, A95% and B5%; 5-7 min, A90% and B10%; 7.7-10 min, A60% and B40%. The assay was repeated 3 times and the recovery of the spiked solution was recorded.
Experimental results show that the three compounds of EIPNA, DIPINA and NDEA in the standard solution are severely inhibited by the matrix (see figures 13-15), namely the substance to be detected and the main drug are mixed and flow out, and the recovery rate is poor.
Comparative example 7
Referring to the detection method of example 1, the only difference is that the elution program will be adjusted to: 0-1 min, A95% and B5%; 5-7 min, A90% and B10%; 7.7-10 min, A60% and B40%. The assay was repeated 3 times and the recovery of the spiked solution was recorded.
The experimental result shows that three impurities in the standard solution are still inhibited, the recovery rate is low, and the detection requirement cannot be met.
Comparative example 8
Referring to the detection method of example 1, the only difference is that the elution program will be adjusted to: 0-4 min, A90% and B10%; 5-7 min, A5% and B95%; 7.1-10 min, A90% and B10%. The assay was repeated 3 times and the recovery of the spiked solution was recorded.
The experimental result shows that after the initial equilibrium proportion is prolonged, three impurities in the standard solution are inhibited, the recovery rate is poor (see fig. 16-18), and the detection requirement cannot be met.
The above embodiments are only used for illustrating the technical solutions of the present application, and not for limiting the same; although the present application has been described in detail with reference to the foregoing embodiments, it should be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions in the embodiments of the present application.

Claims (6)

1. A method for detecting nitrosamine impurities in biapenem is characterized by comprising the following steps:
s1: adding a sample to be tested into a methanol solution of an internal standard substance for dissolving, and then adding a mixed solvent for uniformly mixing to obtain a sample solution;
s2: respectively injecting the sample solution and the reference solution into a liquid chromatography-tandem mass spectrometer, and detecting the content of nitrosamine impurities according to an internal standard method;
in the mixed solvent, the volume ratio of formic acid to methanol to water is 5:10: 85;
the liquid chromatography conditions are as follows: a chromatographic column: a C18 chromatography column; mobile phase A: 0.1% formic acid, mobile phase B: methanol; the column temperature is 38-42 ℃; the flow rate is 0.27-0.33 ml/min;
the elution procedure for the liquid chromatography was: 0-3 min, A95% and B5%; 3.5-4.5 min, A90% and B10%; 5.5-6.5 min, A60% and B40%; 7-8 min, A20% and B80%; 8.1-9.5 min, A0% and B100%; 9.6-12 min, A95% and B5%;
the nitrosamine impurities include N-nitrosodiethylamine, N-nitrosoethylisopropylamine and/or N-nitrosodiisopropylamine.
2. The detection method according to claim 1, wherein the content of methanol in the methanol solution is 50 to 80%.
3. The detection method according to claim 1, wherein the concentration of the internal standard substance in the methanol solution is 30 to 60 ng/ml.
4. The detection method according to claim 1, wherein the volume ratio of the methanol solution to the mixed solvent is 1:20 to 30.
5. The detection method according to claim 1, wherein the concentration of the sample solution is 40 to 80mg/ml, and the concentration of the control solution is 3 to 130 ng/ml.
6. The detection method according to claim 1, wherein the mass spectrometry conditions are: ion source APCI source, scan mode MRM, ion pair comprising: 117.1/75.1, 131.1/89.1 and/or 103.1/47.0, and the collision energy is 15-29V.
CN202111189528.4A 2021-10-13 2021-10-13 Method for detecting nitrosamine impurities in biapenem Active CN113624894B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111189528.4A CN113624894B (en) 2021-10-13 2021-10-13 Method for detecting nitrosamine impurities in biapenem

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111189528.4A CN113624894B (en) 2021-10-13 2021-10-13 Method for detecting nitrosamine impurities in biapenem

Publications (2)

Publication Number Publication Date
CN113624894A true CN113624894A (en) 2021-11-09
CN113624894B CN113624894B (en) 2021-12-28

Family

ID=78391230

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111189528.4A Active CN113624894B (en) 2021-10-13 2021-10-13 Method for detecting nitrosamine impurities in biapenem

Country Status (1)

Country Link
CN (1) CN113624894B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109946396A (en) * 2019-03-26 2019-06-28 深圳市海滨制药有限公司 A method of using high effective liquid chromatography for measuring Biapenem and/or related substance
CN111060616A (en) * 2019-12-17 2020-04-24 上海微谱化工技术服务有限公司 Detection method for nitrosamine impurities in valsartan preparation
CN112129853A (en) * 2020-09-07 2020-12-25 天地恒一制药股份有限公司 Method for detecting nitrosamine impurities in candesartan cilexetil
CN112946107A (en) * 2021-01-28 2021-06-11 石药集团欧意药业有限公司 Analysis method of N-nitrosodimethylamine and N-nitrosodiethylamine in argatroban bulk drug or preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109946396A (en) * 2019-03-26 2019-06-28 深圳市海滨制药有限公司 A method of using high effective liquid chromatography for measuring Biapenem and/or related substance
CN111060616A (en) * 2019-12-17 2020-04-24 上海微谱化工技术服务有限公司 Detection method for nitrosamine impurities in valsartan preparation
CN112129853A (en) * 2020-09-07 2020-12-25 天地恒一制药股份有限公司 Method for detecting nitrosamine impurities in candesartan cilexetil
CN112946107A (en) * 2021-01-28 2021-06-11 石药集团欧意药业有限公司 Analysis method of N-nitrosodimethylamine and N-nitrosodiethylamine in argatroban bulk drug or preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHU-HAN CHANG ET AL.: "A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans", 《JOURNAL OF FOOD AND DRUG ANALYSIS》 *
侯金凤 等: "超高效液相色谱串联质谱法测定缬沙坦原料中4种亚硝胺类基因毒性杂质", 《中国药学杂志》 *

Also Published As

Publication number Publication date
CN113624894B (en) 2021-12-28

Similar Documents

Publication Publication Date Title
Jia et al. Simultaneous determination of 23 amino acids and 7 biogenic amines in fermented food samples by liquid chromatography/quadrupole time-of-flight mass spectrometry
CN107247093B (en) The detection method for metanephrine substance of dissociating in urine
Kataoka et al. Determination of the oxidative stress biomarker urinary 8-hydroxy-2⿲-deoxyguanosine by automated on-line in-tube solid-phase microextraction coupled with liquid chromatography⿿ tandem mass spectrometry
Konda et al. Bioanalytical method development and validation of memantine in human plasma by high performance liquid chromatography with tandem mass spectrometry: application to bioequivalence study
CN113899834B (en) Method for detecting nitrosamine impurities in medicine
Guo et al. Determination of amitraz and its metabolites in whole blood using solid-phase extraction and liquid chromatography–tandem mass spectrometry
Zhou et al. HPLC‐ELSD analysis of spectinomycin dihydrochloride and its impurities
Wang et al. Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry
Chou et al. Solid-phase extraction coupled with liquid chromatography–tandem mass spectrometry for determination of trace rosiglitazone in urine
CN113295805A (en) Method for detecting hydrazine hydrate in medicine
CN113624894B (en) Method for detecting nitrosamine impurities in biapenem
CN110361491B (en) Detection method and kit for simultaneously and accurately quantitatively analyzing human plasma Vicagrel and main metabolites thereof
CN110618215B (en) Quality control product for metabonomics detection and quality control method thereof
Yaroshenko et al. Development and validation of a LC-MS/MS method for d-cycloserine determination in human plasma for bioequivalence study
CN106932502B (en) Method for determining content of 4-chloro-2-picolinic acid methyl ester in sorafenib
Ye et al. Development and validation of a liquid chromatography–tandem mass spectrometry method for topotecan determination in beagle dog plasma and its application in a bioequivalence study
He et al. Simultaneous determination of cyadox and its metabolites in plasma by high‐performance liquid chromatography tandem mass spectrometry
Li et al. Pulse gradient, large-volume injection, high-throughput ultra-performance liquid chromatographic/tandem mass spectrometry bioanalysis for measurement of plasma amrubicin and its metabolite amrubicinol
CN113030343B (en) Liquid chromatography tandem mass spectrometry detection method for pyrroloquinoline quinone in blood plasma
Dahlström et al. Simultaneous determination of codeine and morphine in biological samples by gas chromatography with electron capture detection
Fan et al. Rapid and simultaneous quantitation of amoxicillin and clavulanic acid in human plasma and urine by ultra-performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study
Li et al. Metabolic profiles and pharmacokinetics of goitrin in rats through liquid chromatography combined with electrospray ionization–tandem mass spectrometry
Noh et al. Simultaneous determination of glimepiride and its metabolites in human plasma by liquid chromatography coupled to a tandem mass spectrometry
Li et al. Development and full validation of a liquid chromatography-tandem mass spectrometry method for determination of carbinoxamine in beagle plasma and its application to a pharmacokinetic study
CN114791470A (en) Method for detecting polymyxin in blood by high performance liquid chromatography-tandem mass spectrometry and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant